Invivoscribe Competitors and Similar CompaniesClear all

Invivoscribe's competitors and similar companies include MaveriX Oncology and eTheRNA.
Invivoscribe
Invivoscribe
Invivoscribe is a company providing molecular products and services for leukemia and lymphoma testing.
MaveriX Oncology
MaveriX Oncology
MaveriX Oncology is a biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies.
eTheRNA
eTheRNA
eTheRNA immunotherapies is a biotech company developing immuno-oncology therapies based on its APC-activating messenger RNA platform.
Founding Date
Founding Date
1995
Founding Date
2014
Founding Date
2013
Type
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Shanghai, CN
La Ciotat, FR
Hallbergmoos, DE
Kawasaki, JP
Locations
Palo Alto, US HQ
Locations
Antwerp, BE HQ
Ghent, BE
Hong Kong, HK
Boston, US
Employees
Employees
1981% decrease
Employees
3
Employees
1104% decrease

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 6.5m (over 6 years ago)
Latest funding round
$ 38.3m (almost 6 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
$ 66.3m
For sources of this data, please see the company profile

View Company Profiles

MaveriX Oncology
HQ
Palo Alto, US
Employees
3

MaveriX Oncology is a biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies.

View company
eTheRNA
HQ
Antwerp, BE
Employees
110↓ 4% decrease

eTheRNA immunotherapies is a biotech company developing immuno-oncology therapies based on its APC-activating messenger RNA platform.

View company